275 related articles for article (PubMed ID: 20687180)
1. Integration of small-molecule discovery in academic biomedical research.
Ohlmeyer M; Zhou MM
Mt Sinai J Med; 2010; 77(4):350-7. PubMed ID: 20687180
[TBL] [Abstract][Full Text] [Related]
2. UCSF Small Molecule Discovery Center: innovation, collaboration and chemical biology in the Bay Area.
Arkin MR; Ang KK; Chen S; Davies J; Merron C; Tang Y; Wilson CG; Renslo AR
Comb Chem High Throughput Screen; 2014 May; 17(4):333-42. PubMed ID: 24661212
[TBL] [Abstract][Full Text] [Related]
3. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
4. The role of HTS in drug discovery at the University of Michigan.
Larsen MJ; Larsen SD; Fribley A; Grembecka J; Homan K; Mapp A; Haak A; Nikolovska-Coleska Z; Stuckey JA; Sun D; Sherman DH
Comb Chem High Throughput Screen; 2014 Mar; 17(3):210-30. PubMed ID: 24409957
[TBL] [Abstract][Full Text] [Related]
5. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
Roy A; McDonald PR; Sittampalam S; Chaguturu R
Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
[TBL] [Abstract][Full Text] [Related]
6. The Emory Chemical Biology Discovery Center: leveraging academic innovation to advance novel targets through HTS and beyond.
Johns MA; Meyerkord-Belton CL; Du Y; Fu H
Comb Chem High Throughput Screen; 2014 Mar; 17(3):290-6. PubMed ID: 24409950
[TBL] [Abstract][Full Text] [Related]
7. The role of academic institutions in the development of drugs for rare and neglected diseases.
Coles LD; Cloyd JC
Clin Pharmacol Ther; 2012 Aug; 92(2):193-202. PubMed ID: 22760003
[TBL] [Abstract][Full Text] [Related]
8. [The discovery process in the pharmaceutical industry].
Scatton B
J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
[TBL] [Abstract][Full Text] [Related]
9. Academic drug discovery: current status and prospects.
Everett JR
Expert Opin Drug Discov; 2015; 10(9):937-44. PubMed ID: 26088126
[TBL] [Abstract][Full Text] [Related]
10. How academic labs can approach the drug discovery process as a way to synergize with big pharma.
Loregian A; Palù G
Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. Medicinal chemistry inspired fragment-based drug discovery.
Lanter J; Zhang X; Sui Z
Methods Enzymol; 2011; 493():421-45. PubMed ID: 21371600
[TBL] [Abstract][Full Text] [Related]
13. Principles of early drug discovery.
Hughes JP; Rees S; Kalindjian SB; Philpott KL
Br J Pharmacol; 2011 Mar; 162(6):1239-49. PubMed ID: 21091654
[TBL] [Abstract][Full Text] [Related]
14. Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.
Stewart SR; Barone PW; Bellisario A; Cooney CL; Sharp PA; Sinskey AJ; Natesan S; Springs SL
Clin Pharmacol Ther; 2016 Dec; 100(6):647-653. PubMed ID: 27617845
[TBL] [Abstract][Full Text] [Related]
15. No Denying It: Medicinal Chemistry Training Is in Big Trouble.
Rafferty MF
J Med Chem; 2016 Dec; 59(24):10859-10864. PubMed ID: 27668824
[TBL] [Abstract][Full Text] [Related]
16. New developments in the discovery of small molecule Hedgehog pathway antagonists.
Tremblay MR; McGovern K; Read MA; Castro AC
Curr Opin Chem Biol; 2010 Jun; 14(3):428-35. PubMed ID: 20399136
[TBL] [Abstract][Full Text] [Related]
17. Impact of high-throughput screening in biomedical research.
Macarron R; Banks MN; Bojanic D; Burns DJ; Cirovic DA; Garyantes T; Green DV; Hertzberg RP; Janzen WP; Paslay JW; Schopfer U; Sittampalam GS
Nat Rev Drug Discov; 2011 Mar; 10(3):188-95. PubMed ID: 21358738
[TBL] [Abstract][Full Text] [Related]
18. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
19. Integrating molecular design resources within modern drug discovery research: the Roche experience.
Stahl M; Guba W; Kansy M
Drug Discov Today; 2006 Apr; 11(7-8):326-33. PubMed ID: 16580974
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]